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Abstract
The requirement for large amounts of good quality DNA for whole-genome applications prohibits their use for small, laser
capture micro-dissected (LCM), and/or rare clinical samples, which are also often formalin-fixed and paraffin-embedded
(FFPE). Whole-genome amplification of DNA from these samples could, potentially, overcome these limitations. However,
little is known about the artefacts introduced by amplification of FFPE-derived DNA with regard to genotyping, and
subsequent copy number and loss of heterozygosity (LOH) analyses. Using a ligation adaptor amplification method, we
present data from a total of 22 Affymetrix SNP 6.0 experiments, using matched paired amplified and non-amplified DNA
from 10 LCM FFPE normal and dysplastic oral epithelial tissues, and an internal method control. An average of 76.5% of SNPs
were called in both matched amplified and non-amplified DNA samples, and concordance was a promising 82.4%. Paired
analysis for copy number, LOH, and both combined, showed that copy number changes were reduced in amplified DNA,
but were 99.5% concordant when detected, amplifications were the changes most likely to be ‘missed’, only 30% of non-
amplified LOH changes were identified in amplified pairs, and when copy number and LOH are combined ,50% of gene
changes detected in the unamplified DNA were also detected in the amplified DNA and within these changes, 86.5% were
concordant for both copy number and LOH status. However, there are also changes introduced as ,20% of changes in the
amplified DNA are not detected in the non-amplified DNA. An integrative network biology approach revealed that changes
in amplified DNA of dysplastic oral epithelium localize to topologically critical regions of the human protein-protein
interaction network, suggesting their functional implication in the pathobiology of this disease. Taken together, our results
support the use of amplification of FFPE-derived DNA, provided sufficient samples are used to increase power and
compensate for increased error rates.
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Introduction
High-density genotyping SNP arrays provide an opportunity to
assess the whole genome for multiple effects of genetic instability,
such as copy number changes and loss of heterozygosity (LOH) in
the same DNA sample (Reviewed by Dutt et al. [1]). Unfortunate-
ly, their requirement for relatively large amounts of minimally
fragmented DNA is considered to prohibit the investigation of very
small samples [2], such as when laser capture micro-dissection
(LCM) [2] is required to ensure a homogeneous sample. Samples
from formalin-fixed paraffin embedded (FFPE) material suffer
further problems of reduced DNA extraction efficiency, and
reduced DNA quality due to cross-linking and degradation [3,4].
The use of whole-genome amplification (WGA) offers the potential
to overcome these limitations and for some diseases and tissue
types may be the only way to examine limited clinical samples [5].
Ideally, WGA would amplify DNA without errors, but early
PCR-based methods using random or degenerate primers were
subject to amplification artefacts, incomplete coverage, and low
yield (reviewed by Hughes et al, [5]). Isothermal amplification
methods such as multiple-displacement amplification (MDA) [6]
use random primers and a DNA polymerase such as phi29, that
generates large DNA fragments and has a reduced error rate
compared to Taq polymerase [2]. This is now generally
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fragmented DNA, such as that from FFPE tissues, does not
amplify well with MDA methods because they require high
molecular weight sample DNA [7].
An alternative method for fragmented DNA uses a ligation
adaptor method (such as OmniPlexH) to increase the likelihood of
complete genome coverage [8]. The DNA is initially randomly
fragmented, to average size of 400 bp, and universal adaptors are
ligated to both ends. Adaptor-specific primers and a high-fidelity
polymerase then amplify the fragments by PCR [7,8,9]. This
method has been shown to be comparable to MDA in terms of
genotyping accuracy for unfragmented DNA [9]. Also, because of
its ability to work with small DNA fragments, it is suggested to be
an appropriate method for degraded DNA such as that from FFPE
tissues [8], where fragment sizes are usually within the 300–500 bp
range [3].
In this study, we investigated the use of OmniplexH technology
to amplify DNA extracted from LCM isolated FFPE tissues from
both dysplastic oral epithelium and normal muscle controls, and
compared their subsequent performance on Affymetrix Genome-
wide Human SNP array 6.0 with that of matched-paired un-
amplified gDNA. Furthermore, we provide a systems-wide
overview of aberrations in dysplastic oral epithelium by integrating
genotype information with high confidence human protein-protein
interaction (PPI) network and known cancer phenotypes, using
graph theoretic approaches to show how such data can be valid for
functional analyses.
Results
Normal muscle and at least one dysplastic epithelial sample
were isolated by laser capture micro-dissection (LCM) from
eighteen biopsy samples from six individuals. These tissues ranged
from 3–14 years of storage since processing. At least 1.5 cm
2 of
tissue (from 12 mm thick sections) was required to reliably extract
1 mg DNA from most FFPE tissues. Eight of the tissue samples did
not produce this quantity of DNA due to small sample size. The
ten remaining samples (from four patients) were amplified using
OmniPlexH whole-genome amplification. This procedure ampli-
fied 0.1 mg of DNA to give an average final yield of 2.1 mg (range
0.6–3.2 mg). All samples, both unamplified and amplified, were
able to produce PCR products of at least 350 bp in length. Ten
unamplified genomic DNA samples (gDNA) and ten matched
WGA amplified samples (WGA DNA) were hybridised to
Affymetrix SNP 6.0 arrays (Table S1).
SNP Call Rate and Concordance
Internal method control DNA, extracted from blood, gave
mean SNP call rates of 90.7%60.5. Before filtering the SNPs to
take into account fragment length, the call rates generated by
FFPE gDNA and WGA DNA were on average 90.1%61.2 and
89.8%60.7 respectively. This was reduced by 6–7%, to 84.162.2
and 82.861.6, when a 350 bp fragment length filter described in
the Affymetrix Technical Note [10] and by Jacobs et al, 2007 [4]
was applied (see Table 1). This 350 bp fragment length filter
reduces the SNP repertoire from 909,622 to 131,429.
WGA DNAs produced slightly lower call rates (1.3% lower)
than their gDNA paired counterpart, but the homozygous and
heterozygous call rates were similar between the two groups (see
Table 1). Overall, the homozygous and heterozygous call rates for
FFPE and WGA samples were both only slightly lower than that
for unfragmented control DNA, which were 62.260.5 and
28.560.1 respectively.
The SNPs that failed in the WGA samples (no call) were
compared with the gDNA, to identify allelic amplification bias.
Over half (56.1%65.0) of the SNPs that failed to give a genotype
call in WGA samples, also failed to give a genotype call in the
gDNA matched pair. Of those that did give genotype calls in the
gDNA matched pair, there was no significant difference in the
proportion of allele call rates for AB and BB calls. Yet, AA calls
showed a significant 2.23% decrease on average in call rate (paired
t test, p=0.038, see Table 2).
Of the 131,429 SNPs available for detection, a mean of 76.5%
were called in both the gDNA and WGA matched samples. Of the
SNPs called in both samples, 82.4%65.9 on average were
concordant between the two samples (see Table 3). For control
DNA samples, concordance with matched WGA DNA was higher
at 95.3%. The fragment filter for the control DNA was set at
400 bp because larger DNA fragments were amplifiable from this
sample when compared to the FFPE samples, reflecting the
improved quality of DNA in these samples before the fragmen-
tation step of the amplification procedure.
Paired Copy Number
Paired copy number analysis was performed on DNA from
dysplastic tissues with the Partek Genomics Suite, using SNP 6.0
intensity data (Affymetrix ‘.cel’ files) with the DNA of normal
tissues used as a reference. Differences were analysed between the
paired samples based on the gene involved and the base pair start
and end of the region of change. Changes were described as either
amplification (if the average intensity value was over the diploid
value of 2) or deletion (if under 2). As expected, the number of
copy number changes detected varied greatly between the
different dysplastic samples (gDNA range - 1704 to 6421,
Table 4) reflecting the known genomic instability in the tissues.
Analysis of WGA samples was repeated using WGA normal
tissue DNA as a control. The number of changes also varied (range
1814 to 4897) and, in all but one, was less than the matching
gDNA pair (not shown). A mean of 99.5%60.4 of the changes
detected in both samples were concordant (Table 4). Non-
concordant changes (‘mismatch’ changes – amplified in either the
gDNA or amplified sample and deleted in the other) were very
infrequent in these samples, representing less than 1% of the total
changes in either pair.
However, over half of the changes detected in the gDNA pair
(mean 50.25622.08) were not found in the WGA pair. These
‘missed’ changes were mostly amplifications (mean 34.9%627.7)
rather than deletions (mean 15.4%616.5) when calculated as a
percentage of all gDNA changes (Table 4). In all but one sample
pair, there were more ‘missed’ amplifications than deletions in the
WGA samples. There were also a large number of changes
detected in the WGA pair that were not found in the gDNA pair
(mean 36.4612.6). These ‘extra’ changes were usually deletions
(mean 26.2%613.8) rather than amplifications (mean
10.2%69.0). In all but two sample pairs there were more ‘extra’
deletions than amplifications in the WGA samples.
Paired LOH
Paired LOH analysis was performed on DNA from dysplastic
tissue, with the Partek Genomics Suite using genotyping data
generated by Affymetrix Birdseed (v2) RLMM algorithm (Affyme-
trix ‘.chp’ files) using the DNA of normal tissues as reference. LOH
was detected when a heterozygous SNP in the reference (normal)
sample was detected as homozygous in the test (dysplastic) sample.
Changed regions were analysed between the paired samples based
on the genes involved in the region of change. The number of
LOH changes detected varied greatly between the different
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Table 5).
Analyses of WGA samples were repeated using a WGA normal
tissue DNA as a control. The number of LOH changes also
varied (range 215 to 12624) and showed no trend towards either
an increased or decreased number when compared to the
matching gDNA pair (Table 5). The majority of the LOH
changes detected in gDNA pair were not detected in the WGA
pair (‘missed’ changes mean 73.20%+/222.15) and a similar
number (mean 74.49%+/228.95) of LOH changes in the
amplified pair were not found in the gDNA pair (‘extra’ LOH
changes – see Table 5).
Copy number and LOH Overlap
When the copy number and LOH analyses were overlapped,
the procedure generated data on presence of LOH during
amplifications and deletion, and also on copy neutral LOH
(acquired uniparental disomy) events. Once again, the number
of changes varied greatly between the dysplastic samples, and an
increased number of changes were consistently detected in the
gDNA pairs, when compared to the amplified pairs (mean
values of 7426.764710.3 and 5353.064485.5 respectively,
Table 6).
There was a mean of 4380.863997.0 changes detected in both
gDNA and amplified pairs, and a mean of 86.5%68.9 of these
changes were concordant. Almost 50% of the changes detected in
the gDNA pairs were not found (‘missed’ changes) in the WGA
samples (46.3%616.2 – Table 6, Figure S1), and a mean of
20.9%68.0 of changes in the amplified pairs were not detected in
the gDNA pairs (‘extra’ changes, Figure S1).
Chromosomal Location of ‘missed’ and ‘extra’ changes
In order to assess whether there were any patterns in the
chromosomal location of the changes which were not detected, or
were introduced by the amplification process, the genes identified
as ‘missed’ or ‘extra’ were analysed according to their chromo-
somal start region normalized to chromosome length. This showed
no consistent bias in location to particular chromosomal regions
between different DNA samples (Figure 1).
Functional and topological characterization
A comparison of our findings with the current molecular
knowledge of the genetics of oral carcinoma and premalignancy,
was undertaken using an automated PubMed search of genes
identified in both gDNA and amplified samples (‘experimentally
identified genes’, n=3112) using the keywords ‘oral’, ‘dysplasia’,
‘cancer’ and ‘pre-malignancy’. Of the 3112 experimentally
identified genes, 1375 (44%) had at least one abstract per search
term (Figure 2). Additionally, 1383 of these genes (44%) have
known somatic mutations implicated in cancer, as curated by the
Catalogue of Somatic Mutations in Cancer (COSMIC) database
[11].
To present systems-wide properties of oral genes, experimen-
tally identified genes were mapped onto the high-confidence
human PPI network (see Methods). Interestingly, while 1551
(50%) of these genes could be mapped to the PPI network, 867
genes contained 1270 direct interactions with each other and
formed an oral dysplasia sub-network. This sub-network was
highly modular (modularity=0.79), while the most highly
connected genes included ONECUT1 (n=43 interactions),
GRB2 (n=29 interactions), and HDAC1 (n=24 interactions).
For the 1551/3112 genes that could be mapped to interactome
topological parameters, such as node degree, betweenness,
eigencentrality, and clustering coefficients were calculated
(Figure 3B–E). These topologies were compared to correspond-
ing values for oncogenes (n=171) as well as to essential (n=1331)
and non-essential (n=413) genes (see Methods). The experimen-
tally identified genes appeared to occupy significantly distinct
topological locations compared to non-essential genes, as demon-
strated by higher node degree (p=0.02) and eigencentrality
(p=7.5610
25)( Figure 3B–D). There were no significant
differences in the respective betweenness, centralities and
clustering coefficients. It is also important to note that these
genes’ topologies were significantly different (1.461029#p#0.02)
from oncogenes and essential genes.
Table 1. SNP Call Rates as a percentage of the 131,429 SNPs remained after a 350 bp filter (n=10).
Call Rates
(%) Genomic DNA Amplified DNA
All Homozygous Heterozygous All Homozygous Heterozygous
Range 81.1–87.1 49.2–65.1 22.0–32.2 79.4–84.5 43.6–62.3 21.8–35.8
Mean 84.1 56.5 27.5 82.8 54.4 28.4
St Dev 2.2 5.5 3.4 1.6 5.4 3.9
doi:10.1371/journal.pone.0024503.t001
Table 2. Genotype Distribution of the gDNA overall and the ‘No Calls’ in the amplified DNA (n=10).
Call Rates
(%)
Genotypes
in gDNA
Corresponding gDNA genotype of
the No Call SNPs in amplified DNA
AA AB BB AA AB BB
Range 30.5–37.9 26.6–39.5 29.9–36.8 27.1–35.8 25.0–43.9 28.6–38.3
Mean 33.9 32.9 33.2 31.7 35.6 32.7
St Dev 2.5 4.8 2.4 3.4 7.1 3.8
doi:10.1371/journal.pone.0024503.t002
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The use of SNP genotyping platforms for copy number and
LOH analyses with fragmented DNA has been well described
[3,4,8,12]. DNA from formalin-fixed tissues can be analysed
provided stringent sample quality criteria are met, and the assay
protocol and analysis are adapted accordingly [3,10]. It must be
possible to amplify the DNA to products of at least 300 bp
[3,10,13], and hybridisation of the correct quantity of labelled
PCR product to the chip is critical for copy number analysis. PCR
performance with degraded DNA is less efficient and may require
extra PCR reactions [3,4,10]. When analysing the data for copy
number or LOH, a fragment length filter (based on the achieved
PCR fragment length for each sample) is applied to reduce noise
from SNPs located on large fragments that are inefficiently
amplified [4,10]. With these precautions in place, DNA from
FFPE tissues can be analysed for copy number and LOH [3,4,12].
Despite this, the use of fixed clinical samples remains limited by
physical sample size. Indeed, in this study eight of the available
tissue samples failed to produce enough DNA for this reason.
Amplification is one solution for analysis, and the genotyping of
amplified DNA from good quality samples has previously been
shown to correlate well with paired unamplified DNA [7,8,9,14].
However, the subsequent performance for copy number and LOH
analyses of suboptimal DNA remains contentious [15,16] and the
artefacts introduced by WGA of DNA from FFPE tissues are
unclear. We aimed to determine whether amplified DNA from
FFPE tissues could be used to generate meaningful data for
genotyping, copy number, and LOH changes.
We have presented data from 10 micro-dissected DNA samples
isolated from normal tissue and epithelial dysplasia, with a range
of degrees of chromosomal instability. Part of each sample was
amplified, and then both the unamplified gDNA and amplified
DNA were hybridised to SNP 6.0 chips with appropriate
precautions (Table S1). Filtering sample SNP data to exclude
DNA fragments exceeding 350 bp left 131,429 SNPs for analysis.
SNP fragment size is randomly distributed across the genome, so
that loss in resolution does not compromise information from
specific genomic regions [4], and only reduces the signal ‘noise’
associated with degraded samples [10].
Our internal method control call rate was 90.7% which is in line
with other studies also using DNA from FFPE tissues in the
analysis [3,4]. This reduction in call rate, compared to studies only
using good quality DNA, most likely reflects the effects of the
inclusion of FFPE samples in the Birdseed (v2) RLMM genotyping
learning algorithm. As expected, SNP call rate performance from
unamplified gDNA and amplified DNA from FFPE tissues was
lower than from unfragmented control DNA, but similar to that
found in other studies using FFPE DNA and similar array
platforms [3,4]. Heterozygous and homozygous call rates were
also slightly reduced in a manner consistent with the reduced call
rates in FFPE samples (Table 1). There was no evidence to
suggest a significant reduction in the proportion of heterozygous
call rates caused by allelic dropout in either type of FFPE samples
(gDNA or WGA DNA) during the DNA preparation and array
procedures.
It was encouraging that, of those SNPs that failed to give a
genotype call in the WGA samples, over half also failed to give a
genotype call in the gDNA matched pair. Only homozygous AA
calls showed a significant reduction (2.23%, p=0.038) in no-call
rates in the WGA samples (Figure 1), suggesting that there might
be some allelic amplification bias towards AA calls in the
amplification procedure. On average 76.5% of SNPs were called
in both the matched gDNA and WGA DNA pairs. Of these,
82.4%65.9 were concordant between the two samples (Table 2),
lower than control DNA and its WGA pair (95.3%), but still
correctly calling a large number of the genotypes.
Genotype concordance between unamplified gDNA and
amplified DNA was lower than obtained from good quality
DNA, for which up to 99% has been achieved [6,7,9,14,15]. Mead
et al. achieved a similar concordance level with their degraded (not
FFPE) DNA on early Affymetrix Nsp-Mendal arrays, but only by
filtering the majority of SNPs out of the analysis and thus reducing
the call rate of these samples to 24% [8]. This earlier study was
limited to MDA amplification by the early Affymetrix platforms. It
is to be expected that FFPE DNAs will not perform as well as
control DNA, and the 82.4% concordance between the FFPE
gDNA and its amplified paired DNA should be regarded as an
excellent result.
Paired analysis was performed using a similarly amplified
normal tissue DNA as a reference for the amplified dysplastic
sample. The number of copy number changes detected was
reduced in the WGA DNA samples compared to their matched
gDNA pairs, but concordance (both samples detecting the same
type of change) was high at 99.5%60.4, indicating very few
mismatch changes.
Changes that were ‘missed’ in the amplified pair (50.3%622.1)
were on average twice as likely to be amplifications as deletions,
and changes ‘extra’ to the amplified pair (34.9%627.7) twice as
likely to be deletions as amplifications. These findings are
interesting and complementary, suggesting that the whole-genome
Table 3. SNP call concordance rates (n=10).
SNPs Called in
both samples
Concordant
SNPs
%
Concordance
Range 93905–105786 69135–95057 73.6–90.6
Mean 100599.2 83120.7 82.4
St Dev 3732.2 8908.1 5.9
doi:10.1371/journal.pone.0024503.t003
Table 4. Paired copy number analysis - The number of gene changes and their concordance (n=6).
Number of Changes Concordant Changes
‘missed’ changes
% of gDNA pair
‘extra’ changes
% of WGA pair
gDNA WGA in both Number % Amplification Deletion Amplification Deletion
Range 1704–6429 1814–4897 836–3244 836–3220 98.8–100.0 2.3–69.3 5.0–48.7 1.71–26.17 10.4–52.2
Mean 4076.5 2777.8 1765.8 1755.3 99.5 34.9 15.4 10.2 26.2
St Dev 2047.0 1195.9 811.9 804.0 0.4 27.7 16.5 9.0 13.8
doi:10.1371/journal.pone.0024503.t004
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efficiently, rather than introduced extra copies, most likely due to
the reduced PCR-ability of fragmented DNA.
Our data suggest that around 50% of the changes in the original
FFPE gDNA sample will be accurately detected (mean concor-
dance 95.5%60.4) in the amplified DNA, but that around 50%
will be missed. They also suggest that approximately 35% of the
changes in the amplified DNA will have been introduced.
Disappointingly, less than 30% of the LOH changes in the
gDNA were detected in the amplified DNA. As there was no trend
to reduced numbers of LOH regions detected in amplified pairs,
more than 70% of the changes detected in these samples had been
introduced as artefacts. These findings can be explained either by
allelic dropout during WGA, or failure to genotype correctly due
to increased noise, and the latter is more likely because there is no
increase in homozygous calls in the WGA samples.
The Birdseed genotyping algorithm is a clustering algorithm
[17] and requires training on 50 or more samples for greatest
genotyping accuracy [18]. For this analysis, the 20 samples were
supplemented with HapMap data, increasing the ‘noise in the
system’. Therefore, our concordance for genotyping and LOH is
the minimum achievable, and would improve with additional
samples as the number of ‘missing’ and ‘extra’ changes is reduced.
The ability to overlap copy number and LOH data provides
information about copy neutral LOH (acquired uniparental
disomy). Of those genes detected as changed in both samples,
86.5%68.9 were concordant (both samples detecting the same
type of change e.g. amplification with or without LOH, deletion
with or without LOH, or copy neutral LOH). Interestingly, this
analysis showed the least ‘missed’ and ‘extra’ changes, but still over
45% of the changes in the gDNA sample were still not detected in
the amplified DNA. There was no consistent pattern of
chromosomal location of these ‘missed’ and ‘extra’ changes
between DNA samples, suggesting that they result from random
errors due to the degradation of the DNA, rather than the WGA
procedure itself.
Automated PubMed searches for the 3112 genes that were
identified by changes in both gDNA and amplified samples,
confirms that our results offer a reasonable reflection of the
published repertoire of genes with putative associations with oral
dysplasia and carcinoma. Indeed, 44% of genes identified were
already mentioned in the literature. Additionally, interrogation of
the human PPI network and SNP data revealed that 867 genes
(28%) with genomic changes are linked by 1270 physical protein-
protein interactions, suggesting that these changes may be
functionally relevant. Furthermore, dysplasia-associated genes
occupied topologically central positions in the human interactome,
implying that a genetic disruption in these genes is more likely to
manifest itself in an abnormal phenotype [19,20]. It was of interest
to note that the oncogenes and essential genes had the highest node
degree and betweenness centrality values overall, reinforcing their
alleged detrimental role in disease [20]. These techniques further
support the contention that the data obtained by amplification from
FFPE samples are consistent with general topological principles of
tumorigenesis [21] and have biological relevance, and this
confirmatory data supports the validity of our methods.
In conclusion, our data support the research use of whole-
genome amplification for DNA from FFPE tissues for SNP array
analysis of genotype, copy number, and LOH; although inaccura-
cies preclude its use for diagnosis or treatment planning.
Approximately 50% of the changes detected in the unamplified
DNA will also be detected in the amplified DNA with a very high
accuracy. WGA adds a layer of complexity and a consequent
reduction in reliability. However, analysis remains meaningful, and
concordance would improve as the number of samples increases.
Error rates indicate the importance of an independent measure of
the biological significance of the findings, for instance by functional
bioinformatic comparison. Unlike frozen tissue samples, FFPE
tissues are readily available from pathology archives, and may be
the only type of sample available for research into rare diseases or
longitudinal studies. The use of whole-genome amplification allows
the exploitation of this valuable resource of genetic material for
biomarker and functional genomics studies.
Methods
Ethics Statement
The study was approved by the Guy’s Hospital Research Ethics
Committee and the UK Patient Information Advisory Group,
reference PIAG 4-09(f)2003.
Table 5. Paired LOH analysis - The number of gene changes and their concordance (n=6).
Number of Changes Concordant Changes ‘missed’ LOH ‘extra’ LOH
gDNA WGA In both Number % % of gDNA pair % of WGA pair
Range 77–15446 215–12624 15–10436 15–10436 100 32.4–96.0 17.3–97.5
Mean 3258.5 2725.8 1828.2 1828.2 100 73.2 74.5
St Dev 6018.2 4861.8 4217.9 4219.9 0 22.2 29.0
doi:10.1371/journal.pone.0024503.t005
Table 6. Copy number and LOH overlap - The number of gene changes their concordance (n=6).
Number of Changes Concordant Changes ‘missed’ Overlap ‘extra’ Overlap
gDNA WGA In both Number % % of gDNA pair % of WGA pair
Range 3857–16148 2490–13995 1553–12163 1435–9819 71.0–93.7 24.7–60.6 9.9–29.5
Mean 7426.7 5353.0 4380.8 3693.7 86.5 46.3 20.9
St Dev 4710.3 4485.5 3997.9 3194.9 8.9 16.2 8.0
doi:10.1371/journal.pone.0024503.t006
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Dysplastic oral epithelium and normal muscle were identified in
18 oral mucosal biopsy samples (FFPE), from six individuals, from
the diagnostic pathology archive of the King’s College London
Department of Oral Pathology. Sections were cut at 12 mm
thickness onto UV-treated 1 mm PALM membrane slides (Carl
Zeiss Ltd, Welwyn Garden City, UK) and air dried. Slides were
stained in preparation for LCM, after an overnight incubation at
50uC, using sterile equipment and DNAase-free solutions. The
staining procedure was: removal of paraffin by two 61 minute
incubations in Xylene (Sigma-Aldrich, Dorset, UK), rehydration
of the tissue by decreasing concentrations of ethanol (Sigma-
Aldrich); two 630 second incubations at 100%, a 30 second
incubation at 95%, and 15 seconds in PCR grade water (Fisher
Scientific, Loughborough, UK). The slides were then stained in
Mayer’s haematoxylin (VWR International, Lutterworth, UK) for
5 seconds, and washed in PCR grade water. Slides were
dehydrated in graded ethanol, air dried and then stored at 4uC
for up to one week. LCM of dysplastic epithelium, and normal
underlying muscle, was performed using the PALM MicroBeam
LCM microscope and stored at 220uC.
DNA Extraction and Whole-Genome Amplification
DNA extraction was performed using the QIAamp DNA Micro
kit (Qiagen Ltd, Crawley, UK). The only change to the standard
protocol was to increase the Proteinase K digestion time to three
days with daily additions of 10 ml of Proteinase K (Qiagen Ltd).
Extracted DNA was stored at 220uC and DNA quantity was
calculated using the Quant-iT Picogreen dsDNA kit (Invitrogen,
Paisley, UK).
Amplification of the DNA was performed using GenomePlex
WGA2 kit (Sigma-Aldrich). 100 ng of DNA was amplified and the
Figure 1. Chromosomal distribution of ‘missed’ and ‘extra’ gene changes. Showing the proportion of gene changes (from the copy number
and LOH overlap analysis) identified as either ‘missed’ (white bars) or ‘extra’ (black bars) during the whole-genome amplification procedure and their
chromosomal distribution (normalized to chromosome length). Graphs A–F show data from six different paired normal and dysplasia samples and
compare the data generated using unamplfied (genomic) and amplified DNA. Proportion of changes is represented as a fraction with respect to all
changes detected by a respective methodology.
doi:10.1371/journal.pone.0024503.g001
Figure 2. Automated PubMed search of 3112 genes with
changes in oral dysplasia. Of the 3112 genes, 1375 (44%) had at
least one PubMed cited abstract, suggesting the experimental data
reflected acceptable coverage of current molecular knowledge in oral
dysplasia and carcinogenesis.
doi:10.1371/journal.pone.0024503.g002
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(Sigma-Aldrich). DNA was stored at 220uC and DNA quantity
was calculated as above.
DNA Quality Control PCR
Primer sets were designed using Primer 3 for varying size
amplicons of GAPDH DNA (NI_009759 62 Kb). Primer
sequences are: for 300 bp product – ‘GACTCACCCTGCCCT-
CAATA’ and ‘CCCTGTAGCCTGGACCTGAT’, for 350 bp
product – ‘CACACAGCTAGGGTGCAGAG’ and ‘TTCCAG-
GTCACCCTACAGGA’, and for 400 bp product – ‘AACCGG-
GAAGGAAATGAATG’ and ‘GGGAGCACAGGTAAGTG-
CAT’. The 25 ml PCR reaction included 5 ng DNA, in
HotstartTaq PCR buffer with 2 mM MgCl2, 200 mM per dNTP,
0.2 mM of each primer, and 2.5 U of HotStartTaq (Qiagen). The
PCR cycle was 95uC for 15 minutes, 45 cycles of 94uC for
30 seconds, 53.2uC for 30 seconds, and 72uC for 90 seconds,
followed by a final 72uC incubation for 10 minutes. PCR products
were visualised on a 2100 Bioanalyzer (Agilent Technologies,
Stockport, UK) using DNA 1000 chips (Agilent Technologies).
Affymetrix SNP 6.0 Array Protocol
No changes were made to the Affymetrix SNP 6.0 array
protocol, other than starting with two aliquots of 500 ng DNA per
sample, and performing at least double the number of Nsp and Sty
PCR reactions (in the correct ratios) to achieve the required final
pooled DNA quantity of 200 mg. This DNA was then fragmented,
labelled and hybridised to the SNP 6.0 chip according to
Affymetrix protocols. These changes to the standard protocol
were made according to the Affymetrix Technical note for FFPE
samples [10].
Array Analysis
Hybridised chips were scanned and the resultant intensity ‘.cel’
files were imported into Affymetrix Genotyping console 2. The
Birdseed (v2) RLMM algorithm was used to generate a genotype
for each SNP, using the HapMap SNP 6.0 sample data set to
increase the sample number past the 50 sample minimum
threshold for this algorithm. Subsequent analysis was performed
using the Partek Genomics Suite, filtering data by fragment length
as described in the Affymetrix Technical Note [12] and by Jacobs
et al, 2007 [4]. Genotype concordance was calculated as a
percentage of the number of genotypes that were the same
between two DNA samples, compared to the total number that
were called in both.
Paired analysis (copy number, LOH, and overlap of the two)
was performed with the Partek Genomics Suite, using matched
normal DNA as a reference (Table S1). Gene lists were produced
for each changed region and these were compared between the
non-amplified and amplified samples. Concordance was calculated
as a percentage of the concordant gene changes between the two
pairs, compared to the total number of genes changed in both.
The distribution of ‘missed’ and ‘extra’ gene changes was
measured by identifying the chromosomal start location of a
changed gene (bases) and normalizing that position to the total
number of bases in the respective chromosome. Because genes
contained unequal number of changes, gene frequency was
represented as a fraction of all changes in a sample.
PPI network analysis
A high confidence human PPI network, comprising 57228
interactions among 11203 proteins, was assembled from yeast two-
hybrid experiments, predicted interactions via orthology and co-
Figure 3. Topological analysis of oral dysplasia associated genes. 3A) High confidence human protein-protein interaction (PPI) subnetwork
consisting of 867 genes with changes in oral dysplasia and 1270 interactions. Node color corresponds to distinct gene communities identified by the
Louvain method (see Methods). 3B–E) Comparison of topological properties of oral genes (n=1551), oncogenes (n=171), essential genes (n=1331),
and non-essential genes (n=413) in the PPI network. *p,0.05, **p,0.001 vs. non-essential. MEAN6SEM.
doi:10.1371/journal.pone.0024503.g003
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represented as an undirected and unweighted graph where
proteins correspond to nodes, and interactions between them
correspond to edges. Gene-phenotype information was download-
ed from the Mouse Genome Database (MGD) [23] and each
mouse transcript was mapped to the respective human homologue
using the Ensembl genome browser [24]. Oncogenes, essential,
and non-essential genes sets were selected if allelic mutations in a
single gene manifested in tumor, lethal, or absent phenotypes
respectively. To evaluate node degree, betweenness, eigencentral-
ity, and clustering coefficients associated with each gene set,
individual genes were mapped to the human PPI network. Node
degree is defined as the total number of interactions that connect
to a given gene Betweenness is the measure of gene importance
within the network, where genes that occur on many shortest paths
between other genes have higher betweenness. Eigencentrality is a
measure for how well connected a gene is to other highly
connected genes in a network. Clustering coefficient is the degree
to which genes tend to cluster together [25]. Statistical significance
of differential topology values was measured using the Wilcoxon
rank sum test. P-values#0.05 were considered significant. The
Louvain method for optimizing modularity was used to estimate
the tendency of nodes in the PPI to form communities [25].
Supporting Information
Figure S1 Comparison of changes between Non-ampli-
fied gDNA and Amplified DNA. Showing the average
percentage of changes identified in amplified samples as a
percentage of the non-amplified samples. Changes are represented
as concordant (blue) and non-concordant (red) between the two
sample types. Changes only identified in the non-amplified
samples, therefore, ‘missed’ in the amplified samples are green,
and only in the amplified samples, therefore ‘extra’ are purple.
(TIF)
Table S1 Affymetrix SNP 6.0 Array Sample Informa-
tion. Showing the number of individual SNP 6.0 array datasets
produced using DNA from formalin fixed paraffin embedded
tissues and a blood internal method control. Matched paired
gDNA and whole genome amplified DNA was used from 10 tissue
samples (both normal and dysplastic tissues) taken from biopsies
from four patients. Patients with multiple dysplastic epithelium
samples were taken at least 6 months apart.
(DOCX)
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